The up-regulation of histone deacetylase 8 promotes proliferation and inhibits apoptosis in hepatocellular carcinoma (Q39090052)

9 September 2017

The up-regulation of histone deacetylase 8 promotes proliferation and inhibits apoptosis in hepatocellular carcinoma (English)

1 reference

9 September 2017

Jian Wu

1

1 reference

9 September 2017

Chengli Du

2

1 reference

9 September 2017

Zhen Lv

3

1 reference

9 September 2017

Chaofeng Ding

4

1 reference

9 September 2017

Jun Cheng

5

1 reference

9 September 2017

Haiyang Xie

6

1 reference

9 September 2017

Lin Zhou

7

1 reference

9 September 2017

Shusen Zheng

8

1 reference

9 September 2017

1 December 2013

1 reference

Digestive Diseases and Sciences

9 September 2017

1 reference

9 September 2017

58

1 reference

9 September 2017

3545-3553

1 reference

9 September 2017

12

1 reference

https://scigraph.springernature.com/pub.10.1007/s10620-013-2867-7

9 September 2017

0 references

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2867-7

The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2867-7

Histone deacetylases and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2867-7

Histone deacetylase inhibitors: Potential in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2867-7

Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2867-7

Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2867-7

Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2867-7

Histone deacetylase-1 and -3 protein expression in human breast cancer: a tissue microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2867-7

Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2867-7

Expression of class I histone deacetylases indicates poor prognosis in endometrioid subtypes of ovarian and endometrial carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2867-7

Expression of histone deacetylase 8, a class I histone deacetylase, is restricted to cells showing smooth muscle differentiation in normal human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2867-7

Histone deacetylase 8 in neuroblastoma tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2867-7

Loss of Gelsolin expression in human ovarian carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2867-7

Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2867-7

Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2867-7

Connected to death: the (unexpurgated) mitochondrial pathway of apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2867-7

14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2867-7

p53-Induced apoptosis and inhibitors of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2867-7

Apoptosis - the p53 network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2867-7

Histone deacetylase inhibitors differentially stabilize acetylated p53 and induce cell cycle arrest or apoptosis in prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2867-7

Retracted: Identification of Histone Deacetylase 3 as a Biomarker for Tumor Recurrence Following Liver Transplantation in HBV-Associated Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2867-7

Apoptosis pathways in cancer and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2867-7

Mitochondrial signaling in cell death via the Bcl-2 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2867-7

Targeting the p53 pathway of apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2867-7

Control of apoptosis by p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2867-7

Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2867-7

The role of p53 in apoptosis.

21 January 2018

1 reference

12 December 2020

Histone deacetylases 1, 6 and 8 are critical for invasion in breast cancer.

1 reference

12 December 2020

Combination of polymorphisms within the HDAC1 and HDAC3 gene predict tumor recurrence in hepatocellular carcinoma patients that have undergone transplant therapy.

1 reference

12 December 2020

NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma

1 reference

12 December 2020

Primary prevention of hepatocellular carcinoma in developing countries.

1 reference

12 December 2020

10.1007/S10620-013-2867-7

Identifiers

DOI

1 reference

release_sbr354avtzaibbg5fn75twlgve

9 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sbr354avtzaibbg5fn75twlgve

24 November 2022

mapped directly with Wikidata item

1 reference